Exogenous insulin treatment after hypofractionated radiotherapy in cats with diabetes mellitus and acromegaly

Journal of Veterinary Internal Medicine

Volumn 23, Issue 2, 2009, Pages 243-249

  Dunning, M D ^a   Lowrie, C S ^b   Bexfield, N H ^a   Dobson, J M ^a   Herrtage, M E ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b Tudor Lodge   (United Kingdom)

Author keywords

Fructosamine; IGF 1; Insulin; Pituitary; Prognosis

Indexed keywords

ANIMALIA; FELIDAE;

FRUCTOSAMINE; INSULIN; SOMATOMEDIN C;

ACROMEGALY; ANIMAL; ANIMAL DISEASE; ARTICLE; BLOOD; CAT; CAT DISEASE; FEMALE; GLUCOSE BLOOD LEVEL; INSULIN DEPENDENT DIABETES MELLITUS; MALE; METABOLISM; RETROSPECTIVE STUDY;

ACROMEGALY; ANIMALS; BLOOD GLUCOSE; CAT DISEASES; CATS; DIABETES MELLITUS, TYPE 1; FEMALE; FRUCTOSAMINE; INSULIN; INSULIN-LIKE GROWTH FACTOR I; MALE; RETROSPECTIVE STUDIES;

EID: 66149141089     PISSN: 08916640     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1939-1676.2008.0242.x     Document Type: Article

References (48)

1. Hurty CA, Flatland B. Feline acromegaly: A review of the syndrome. J Am Anim Hosp Assoc 2005;41:292-297.
2. Selman PJ, Mol JA, Rutteman GR, et al. Progestin-induced growth hormone excess in the dog originates in the mammary gland. Endocrinology 1994;134:287-292.
3. Ayuk J, Sheppard MC. Growth hormone and its disorders. Postgrad Med J 2006;82:24-30.
4. Colao A, Ferone D, Marzullo P, Lombardi G. Systemic complications of acromegaly: Epidemiology, pathogenesis, and management. Endocr Rev 2004;25:102-152.
5. Starkey SR, Tan K, Church DB. Investigation of serum IGF-1 levels amongst diabetic and non-diabetic cats. J Feline Med Surg 2004;6:149-155.
6. Lewitt MS, Hazel SJ, Church DB, et al. Regulation of insulinlike growth factor-binding protein-3 ternary complex in feline diabetes mellitus. J Endocrinol 2000;166:21-27.
7. Reusch CE, Kley S, Casella M, et al. Measurements of growth hormone and insulin-like growth factor 1 in cats with diabetes mellitus. Vet Rec 2006;158:195-200.
8. Berg RIM, Nelson RW, Feldman EC, et al. Serum insulin-like growth factor-I concentration in cats with diabetes mellitus and acromegaly. J Vet Intern Med 2007;21:892-898.
9. Giustina AA, Barkan FF, Casanueva F, et al. Criteria for cure of acromegaly: A consensus statement. J Clin Endocrinol Metab 2000;85:526-529.
10. Dimaraki EV, Jaffe CA, DeMott-Friberg R, et al. Acromegaly with apparently normal GH secretion: Implications for diagnosis and follow-up. J Clin Endocrinol Metab 2002;87:3537-3542.
11. Elliott DA, Feldman EC, Koblik PD, et al. Prevalence of pituitary tumors among diabetic cats with insulin resistance. J Am Vet Med Assoc 2000;216:1765-1768.
12. Goossens MM, Feldman EC, Nelson RW, et al. Cobalt 60 irradiation of pituitary gland tumors in three cats with acromegaly. J Am Vet Med Assoc 1998;213:374-376.
13. Mayer MN, Greco DS, LaRue SM. Outcomes of pituitary tumor irradiation in cats. J Vet Intern Med 2006;20:1151-1154.
14. Peterson ME, Taylor RS, Greco DS, et al. Acromegaly in 14 cats. J Vet Intern Med 1990;4:192-201.
15. Littler RM, Polton GA, Brearley MJ. Resolution of diabetes mellitus but not acromegaly in a cat with a pituitary macroadenoma treated with hypofractionated radiation. J Small Anim Pract 2006;47:392-395.
16. Brearley MJ, Polton GA, Littler RM, Niessen SJM. Coarse fractionated radiation therapy for pituitary tumours in cats: A retrospective study of 12 cases. Vet Comp Onc 2006;4:209-217.
17. Lichtensteiger CA, Wortman JA, Eigenmann JE. Functional pituitary acidophil adenoma in a cat with diabetes mellitus and acromegalic features. Vet Pathol 1986;23:518-521.
18. Abrams-Ogg ACG, Holmberg DL, Stewart WA, Claffey FP. Acromegaly in a cat: Diagnosis by magnetic resonance imaging and treatment by cryohypophysectomy. Can Vet J 1993;34:682-685.
19. Norman EJ, Mooney CT. Diagnosis and management of diabetes mellitus in five cat with somatotrophic abnormalities. J Feline Med Sur 2000;1:183-190.
20. Abraham LA, Helmond SE, Mitten RW, et al. Treatment of an acromegalic cat with the dopamine agonist L-deprenyl. Aust Vet J 2002;80:479-483.
21. Morrison SA, Randolph JF, Lothrop CD. Hypersomatotropism and insulin-resistant diabetes mellitus in a cat. J Am Vet Med Assoc 1989;194:192-201.
22. Middleton DJ, Culvenor JA, Vasak E, et al. Growth hormone-producing pituitary adenoma, elevated serum somatomedin C concentration and diabetes mellitus in a cat. Can Vet J 1985;26: 169-171.
23. Eigenmann JE, Wortman JA, Haskins ME. Elevated growth hormone levels and diabetes mellitus in a cat with acromegalic features. J Am Anim Hosp Assoc 1984;20:747-752.
24. Lissett CA, Peacey SR, Laing IL, et al. The outcome of surgery for acromegaly: The need for a specialist pituitary surgeon for all types of growth hormone (GH) secreting adenoma. Clin Endocrinol (Oxford) 1998;49:653-657.
25. Biermasz NR, van Dulken H, Roelfsema F. Long-term follow-up results of postoperative radiotherapy in 36 patients with acromegaly. J Clin Endocrinol Metab 2000;85:2476-2482.
26. Burt MG, Ho KK. Newer options in the management of acromegaly. Intern Med J 2006;36:437-444.
27. Thalassinos NC, Tsagarakis S, Ioannides G, et al. Megavoltage pituitary irradiation lowers but seldom leads to safe GH levels in acromegaly: A long-term follow-up study. Eur J Endocrinol 1998;138:160-163.
28. Barkan AL, Halasz I, Dornfeld KJ, et al. Pituitary irradiation is ineffective in normalizing plasma insulin-like growth factor I in patients with acromegaly. J Clin Endocrinol Metab 1997;82: 3187-3191.
29. Biermasz NR, van Thiel SW, Pereira AM, et al. Decreased quality of life in patients with acromegaly despite long-term cure of growth hormone excess. J Clin Endocrinol Metab 2004;89:5369-5376.
30. Littley MD, Shalet SM, Swindell R, et al. Low-dose pituitary irradiation for acromegaly. Clin Endocrinol (Oxford) 1990;32:261-270.
31. Feldman EC, Nelson RW. Disorders of growth hormone. In: Feldman EC, Nelson RW, eds. Canine and Feline Endocrinology and Reproduction, 3rd ed. Philadelphia, PA: WB Saunders; 2004:45-84.
32. Thomas SJ, Thomas RL. A beam generation algorithm for linear accelerators with independent collimators. Phys Med Biol 1990;35:325-332.
33. Thomas SJ. A modified power-law formula for inhomogeneity corrections in beams of high-energy x rays. Med Phys 1991;18:719-723.
34. Popovic V. Acromegaly-Evolving strategies. Pediatr Endocrinol Rev 2004;1(Suppl 3):496-500.
35. Kaser-Hotz B, Rohrer CR, Stankeova S, et al. Radiotherapy of pituitary tumours in five cats. J Small Anim Pract 2002;43:303-307.
36. Brearley MJ, Jeffery ND, Phillips SM, Dennis R. Hypofractionated radiation therapy of brain masses in dogs: A retrospective analysis of survival of 83 cases (1991-1996). J Vet Intern Med 1999;13:408-412.
37. Clemmons DR. Roles of insulin-like growth factor-I and growth hormone in mediating insulin resistance in acromegaly. Pituitary 2002;5:181-183.
38. Anniko M, Wersall J. Morphological effects in pituitary tumours following radiotherapy. Virchows Arch A Pathol Anat Histol 1982;395:45-58.
39. Anniko M, Arndt J, Rahn T, Werner S. Gamma irradiation effects on human growth hormone producing pituitary adenoma tissue. An analysis of morphology and hormone secretion in an in vitro model system. Acta Otolaryngol 1982;93:485-500.
40. Popovic V. Are there alternative tests for diagnosis of acromegaly? J Endocrinol Invest 2005;28:73-74.
41. Biermasz NR, Dekker FW, Pereira AM, et al. Determinants of survival in treated acromegaly in a single center: Predictive value of serial insulin-like growth factor I measurements. J Clin Endocrinol Metab 2004;89:2789-2796.
42. Arita K, Kurisu K, Tominaga A, et al. Slow postoperative decline in blood concentration of insulin-like growth factor-1 (IGF-1) in acromegalic patients. Endocr J 2005;52:125-130.
43. Jenkins PJ, Bates P, Carson MN, et al. Conventional pituitary irradiation is effective in lowering serum growth hormone and insulin-like growth factor-I in patients with acromegaly. J Clin Endocrinol Metab 2006;91:1239-1245.
44. Powell JS, Wardlaw SL, Post KD, Freda PU. Outcome of radiotherapy for acromegaly using normalization of insulin-like growth factor I to define cure. J Clin Endocrinol Metab 2000;85: 2068-2071.
45. van der Lely AJ, de Herder WW, Janssen JA, Lamberts SW. Acromegaly: The significance of serum total and free IGF-I and IGF-binding protein-3 in diagnosis. J Endocrinol 1997;155 (Suppl 1):S9-S13.
46. Frystyk J, Ivarsen P, Stoving RK, et al. Determination of free insulin-like growth factor-I in human serum: Comparison of ultrafiltration and direct immunoradiometric assay. Growth Horm IGF Res 2001;11:117-127.
47. Feelders RA, Bidlingmaier M, Strasburger CJ, et al. Postoperative evaluation of patients with acromegaly: Clinical significance and timing of oral glucose tolerance testing and measurement of (free) insulin-like growth factor I, acid-labile subunit, and growth hormone-binding protein levels. J Clin Endocrinol Metab 2005;90:6480-6489.
48. Kokka N, Garcia JF, Morgan M, George R. Immunoassay of plasma growth hormone in cats following fasting and administration of insulin, arginine, 2-deoxyglucose and hypothalamic extract. Endocrinology 1971;88:359-366.